Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials

Extended Release Quetiapine Fumarate Monotherapy for Major Depressive Disorder: Results of a Double-Blind, Randomized, Placebo-Controlled Study

(2016) Richard Weisler et al.   CNS SPECTRUMS

Benefits From Antidepressants

(2012) Robert D. Gibbons et al.   ARCHIVES OF GENERAL PSYCHIATRY

Effect of Quetiapine and Norquetiapine on Anxiety and Depression in Major Psychoses Using a Pharmacokinetic Approach

(2012) A. Carlo Altamura et al.   CLINICAL DRUG INVESTIGATION

Quetiapine

(2012) Mark Sanford et al.   CNS DRUGS

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial

(2011) Eirik Kjelby et al.   BMC Psychiatry

Quetiapine for bipolar depression

(2011) Alberto Chiesa et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Understanding the Burden of Depression

(2011) Larry Culpepper   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial

(2010) Michael Liebowitz et al.   DEPRESSION AND ANXIETY

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study☆

(2010) Brian Bortnick et al.   JOURNAL OF AFFECTIVE DISORDERS

Impact of Second-Generation Antipsychotics and Perphenazine on Depressive Symptoms in a Randomized Trial of Treatment for Chronic Schizophrenia

(2010) Donald E. Addington et al.   JOURNAL OF CLINICAL PSYCHIATRY

Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder

(2010) George I. Papakostas et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression

(2009) Michael Bauer et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

The under-recognized role of dopamine in the treatment of major depressive disorder

(2009) Stuart A. Montgomery   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder

(2009) Andrew J. Cutler et al.   JOURNAL OF CLINICAL PSYCHIATRY

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

(2009) Andrea Cipriani et al.   LANCET

Preclinical mechanisms for the broad spectrum of antipsychotic, antidepressant and mood stabilizing properties of Seroquel®

(2008) J.M. Goldstein et al.   EUROPEAN PSYCHIATRY

Clinical impact of duloxetine treatment on sleep in patients with major depressive disorder

(2008) Stephan Brecht et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

(2007) George I. Papakostas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY